Project Grant R21AG091424
Award Date
1/15/25
Completion Date
12/31/26
Dollars Obligated
$429K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support Emory University's research into the genetic regulation of brain transcriptomics and proteomics associated with Alzheimer's disease and related dementias. The $528,876 award, effective June 1, 2025, will fund the development of new analytic tools to integrate genomic data across multiple tissues and improve the identification of genetic risk factors and underlying molecular mechanisms for...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $663,376 to The Regents of the University of California, San Francisco to explore the molecular mechanisms underlying the heterogeneity of Alzheimer's disease and related dementias. The project aims to identify key genes that mediate the selective vulnerability of brain regions to distinct pathological protein conformers, such as tau and alpha-synuclein, using a novel computational modeling...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $124,050.00 to The Regents of the University of California, San Francisco (UCSF) to investigate the molecular mechanisms underlying synapse loss in Alzheimer's disease (AD). The key objectives are to: 1) Determine how IL-6 and IL-11 signaling pathways affect synaptic phosphatidylserine (PS) exposure, glial synaptic engulfment, and in vivo synaptic function in AD models; and 2) Identify other...
The National Institutes of Health's National Institute on Aging awarded a $7,432,562 project grant to the Regents of the University of California, San Francisco on September 15, 2022 under the Aging Research program (CFDA 93.866). The grant will support research to elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes through 2025. Specifically, the University of California, San Francisco will use CRISPR and single-cell RNA sequencing...
The National Institute on Aging (NIA) awarded a $312,000 Project Grant (CFDA 93.866 - Aging Research) to The Medical College of Wisconsin, Inc. to investigate the impact of late-onset Alzheimer's disease (LOAD)-associated genes on neurodegeneration and Alzheimer's-related neurotoxicity using the C. elegans model system. The 2-year project, running from June 1, 2025 to May 31, 2027, aims to bridge the knowledge gap on the genetic basis of Alzheimer's disease by exploring how LOAD-associated genes...
This Project Grant award of $628,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate how Alzheimer's disease (AD) pathogenesis interferes with synaptic autophagy and whether targeting synaptic autophagy can be neuroprotective in an AD mouse model. The research will utilize primary hippocampal cell cultures and mouse models to determine which steps in the autophagic processing of synaptic proteins are disrupted by AD, and evaluate if overexpressing the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $913,225.00 in funding to St. Jude Children's Research Hospital Inc. to conduct research on Alzheimer's disease (AD) and AD-related dementias (ADRD). The project aims to systematically characterize the aggregation of U1 small nuclear ribonucleoprotein (U1 SNRNP) and its role in RNA splicing dysfunction, a key event in AD pathogenesis. The research will utilize human brain specimens, mouse...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $498,748.00 to the University of Massachusetts Medical School (UMass Medical) to elucidate the mechanisms by which MS4A genes regulate neurodegeneration in Alzheimer's disease and related disorders. The project aims to investigate the effects of deleting other MS4A family members, individually or in combination, on neurodegenerative phenotypes in mouse models. Additionally, the research will...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $454,271 to Florida Atlantic University to investigate the role of amyloid precursor protein (APP) and cholesterol homeostasis in synaptic dysfunction and neurodegeneration related to Alzheimer's disease (AD). The research aims to use human neurons derived from induced pluripotent stem cells (hiNs) to systematically study how mutations affecting APP distribution, trafficking, and interaction...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,929,011 to The Regents of the University of California, San Francisco (UCSF) to conduct a longitudinal, multimodal neuroimaging study investigating the role of neuronal dysfunction and hyperexcitability in the early biological progression of Alzheimer's disease. The study aims to elucidate the earliest manifestations of neural circuit hyperexcitability that predict the accumulation of tau...